Capital Research Global Investors
PBH icon

Capital Research Global Investors’s Prestige Consumer Healthcare PBH Stock Holding History

Capital Research Global Investors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-894,679
Closed -$53M – 467
2026
Q1 		$53M Buy
894,679
+333,182
+59% +$21.6M 0.01% 354
2025
Q4 		$34.6M Buy
561,497
+291,425
+108% +$17.8M 0.01% 369
2025
Q3 		$16.9M Sell
270,072
-25,838
-9% -$1.8M ﹤0.01% 406
2025
Q2 		$23.6M Buy
+295,910
New +$24.8M ﹤0.01% 384

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors's PBH Position: Q2 2026 in Review

Capital Research Global Investors sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 894,679 shares — an estimated $53M sold.

Capital Research Global Investors first reported a position in PBH in Q2 2025 and held it in 4 quarters. The position peaked at $53M in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Capital Research Global Investors reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Capital Research Global Investors sold 894,679 Prestige Consumer Healthcare shares in Q2 2026, an estimated $53M.
  • Capital Research Global Investors first reported a position in Prestige Consumer Healthcare in Q2 2025 and held it in 4 quarters.
  • Capital Research Global Investors's Prestige Consumer Healthcare position peaked at $53M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.